In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Eivina Radzevičiūtė-ValčiukėDepartment of Immunology and Bioelectrochemistry, State Research Institute Centre for Innovative Medicine, LT-08410 Vilnius, Lithuania.ORCID 0000-0003-4588-7576 Austėja BalevičiūtėDepartment of Immunology and Bioelectrochemistry, State Research Institute Centre for Innovative Medicine, LT-08410 Vilnius, Lithuania.ORCID 0000-0003-2179-5394 Augustinas ŽelvysDepartment of Immunology and Bioelectrochemistry, State Research Institute Centre for Innovative Medicine, LT-08410 Vilnius, Lithuania.ORCID 0000-0002-1952-0431 Karolina SuveizdėLaboratory of Immunology, National Cancer Institute, LT-08660 Vilnius, Lithuania.
Auksė ZinkevičienėDepartment of Immunology and Bioelectrochemistry, State Research Institute Centre for Innovative Medicine, LT-08410 Vilnius, Lithuania.
Vytautas KašėtaDepartment of Stem Cell Biology, State Research Institute Centre for Innovative Medicine, LT-08410 Vilnius, Lithuania.ORCID 0000-0001-9702-3062 Veronika Malyško-PtašinskėDepartment of Immunology and Bioelectrochemistry, State Research Institute Centre for Innovative Medicine, LT-08410 Vilnius, Lithuania.ORCID 0000-0002-2438-5713 Neringa DobrovolskienėLaboratory of Immunology, National Cancer Institute, LT-08660 Vilnius, Lithuania.ORCID 0000-0001-8044-8910 Vita PašukonienėLaboratory of Immunology, National Cancer Institute, LT-08660 Vilnius, Lithuania.
Jurij NovickijFaculty of Electronics, Vilnius Gediminas Technical University, LT-10105 Vilnius, Lithuania.
Irutė GirkontaitėDepartment of Immunology and Bioelectrochemistry, State Research Institute Centre for Innovative Medicine, LT-08410 Vilnius, Lithuania.ORCID 0000-0002-3659-3202 Vitalij NovickijDepartment of Immunology and Bioelectrochemistry, State Research Institute Centre for Innovative Medicine, LT-08410 Vilnius, Lithuania.ORCID 0000-0001-6147-956X Funding
Lietuvos Mokslo Taryba S-PD-24-124
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
carcinomadendritic cellselectroporationmurinemyelomapulsed electric fields
Identifiers
PMID40733014
PMCPMC12299573
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390